|
Title
|
Type
|
Submission Type |
Organizer |
Cosponsor |
Description |
| Accelerating Hit-To-Lead Optimization Through Reaction Prediction (Invited) |
Oral |
Invited |
|
|
H2L reaction prediction
|
| An Expanded Hit Discovery Toolbox (Invited) |
Oral |
Invited |
|
|
Screening and hit prediction strategies
|
| Beyond the KD: Decoding the Thermodynamics and Kinetics of Molecular Recognition (Invited) |
Oral |
Invited |
|
|
Leveraging enthalpy, entropy, and binding kinetics for precision drug design
|
| Beyond the Rule of 5: Addressing the ADME Puzzle for Heterobifunctional Molecules (Invited) |
Oral |
Invited |
|
|
Symposium is targeting the key PK difficulties with BR05 compounds, specifically heterobifunctional ...
|
| Biopharma 101: Transition to Industry (Invited) |
Oral |
Invited |
|
|
|
| Expanding the Covalent Toolbox: Non-Canonical Warheads in Drug Discovery (Invited) |
Oral |
Invited |
|
|
Evaluation of new and novel covalent warheads
|
| Extending the Clock: Strategies to Boost MRT (Invited) |
Oral |
Invited |
|
|
Medicinal chemistry strategies to improve drug properties
|
| First Time Disclosure (Invited) |
Oral |
Invited |
|
|
Symposium highlighting the first time disclosure of clinical candidates
|
| Innovation and Acceleration Through Drug Discovery Partnerships (Invited) |
Oral |
Invited |
|
|
Collaborative strategies to accelerate drug discovery
|
| Is First-In-Class Enough? Medicinal Chemistry Strategies to Overcome Resistance and Redefine Best-In-Class (Invited) |
Oral |
Invited |
|
|
Reevaluating first-in-class versus best-in-class
|
| MEDI Awards Sessions (Invited) |
Oral |
Invited |
|
|
MEDI Awards
|
| MEDI General Oral Sessions |
Oral |
Contributed |
|
|
General oral session from contributed abstracts
|
| MEDI Poster Session |
Poster |
Contributed |
|
|
For MEDI General Posters
|
| Medicinal Chemist's Toolbox: Binding Kinetics, Symmetry, and Polyvalency in Drug Design (Invited) |
Oral |
Invited |
|
|
A toolbox for chemists to assess kinetics and how that effects drug design
|
| Targeting Neurodegeneration: Key Lessons and New Directions in Drug Discovery for Alzheimer’s and Related Disorders (Invited) |
Oral |
Invited |
|
|
|
